Internal Medicine, Interventional Cardiology · Roslyn, NY
NPI
1730192709
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
100 Port Washington Blvd, Suite 105
Roslyn, NY, 11576
Phone (516) 390-9640
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
5,638 services
Medicare patients, 2024
3,591
Average age 76
Drug cost, 2024
$2.1M
11,714 prescriptions
Company payments, 2025
$867
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard A Shlofmitz was code 99213 (office e&m - established), 1,755 times for 1,642 patients. In total Richard A Shlofmitz billed 5,638 services in 45 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,755 | 1,642 | $76.61 | $134K |
| 93458 Percutaneous Transcatheterization | Facility | 1,215 | 1,192 | $239.56 | $291K |
| 92928 Percutaneous Coronary Artery Angioplasty and Stenting | Facility | 576 | 459 | $541.11 | $312K |
| 92978 Echocardiography (TTE/TEE) | Facility | 523 | 454 | $89.55 | $47K |
| 99214 Office E&M - Established | Office | 256 | 250 | $111.91 | $29K |
| 93454 Percutaneous Transcatheterization | Facility | 227 | 223 | $207.52 | $47K |
| 93000 Electrocardiogram | Office | 175 | 174 | $12.46 | $2,181 |
| 93459 Percutaneous Transcatheterization | Facility | 162 | 152 | $254.83 | $41K |
| 99212 Office E&M - Established | Office | 127 | 127 | $34.79 | $4,418 |
| 93246 Electrocardiogram | Office | 72 | 71 | $11.07 | $797 |
| 93455 Percutaneous Transcatheterization | Facility | 66 | 60 | $218.35 | $14K |
| 93460 Percutaneous Transcatheterization | Facility | 65 | 65 | $326.06 | $21K |
| 92972 Percutaneous Coronary Artery Angioplasty and Stenting | Facility | 50 | 48 | $132.94 | $6,647 |
| 92920 Percutaneous Coronary Artery Angioplasty and Stenting | Facility | 44 | 41 | $444.77 | $20K |
| 92979 Echocardiography (TTE/TEE) | Facility | 41 | 38 | $70.82 | $2,904 |
By year: 2022 $901K for 5,414 services; 2023 $946K for 5,736 services; 2024 $1.0M for 5,638 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard A Shlofmitz prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,159 prescriptions and refills. In total Richard A Shlofmitz wrote 11,714 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,159 | 3,280 | 401 | $13K |
| Metoprolol Succinate Generic | 1,148 | 3,210 | 399 | $19K |
| Rosuvastatin Calcium Generic | 870 | 2,502 | 346 | $13K |
| Prasugrel Hcl Generic | 464 | 1,234 | 191 | $35K |
| Amlodipine Besylate Generic | 455 | 1,286 | 173 | $3,999 |
| Valsartan Generic | 446 | 1,170 | 158 | $13K |
| Clopidogrel Clopidogrel Bisulfate | 445 | 1,279 | 172 | $5,845 |
| Xarelto Rivaroxaban | 420 | 967 | 145 | $526K |
| Eliquis Apixaban | 369 | 845 | 130 | $480K |
| Losartan Potassium Generic | 365 | 1,046 | 143 | $3,743 |
| Furosemide Generic | 287 | 727 | 129 | $1,849 |
| Ezetimibe Generic | 270 | 763 | 96 | $7,299 |
| Repatha Sureclick Evolocumab | 263 | 406 | 66 | $226K |
| Hydrochlorothiazide Generic | 187 | 461 | 68 | $632 |
| Entresto Sacubitril/Valsartan | 165 | 314 | 52 | $202K |
Brand drugs: 1,763 claims; generic drugs: 9,951 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard A Shlofmitz $867 ($867 in general payments such as food, travel and fees) from 8 companies. The largest payer was Abbott Laboratories with $246.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.